Management of diabetes in patients with COVID-19 - Authors' reply.
Saved in:
| Title: | Management of diabetes in patients with COVID-19 - Authors' reply. |
|---|---|
| Authors: | Bornstein SR; Department of Medicine III and Paul Langerhans Institute Dresden, Helmholtz Center Munich, University Hospital Carl Gustav Carus, Dresden, Germany; Department of Diabetes, School of Life Course Science and Medicine, King's College London, London, UK; Department of Endocrinology and Diabetology, University Hospital Zurich, Zurich, Switzerland; Faculty of Medicine, Technische Universität Dresden, Dresden, Germany; German Center for Diabetes Research, Neuherberg, Germany. Electronic address: stefan.bornstein@uniklinikum-dresden.de., Zimmet P; Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia., Rubino F; Department of Diabetes, School of Life Course Science and Medicine, King's College London, London, UK; Bariatric and Metabolic Surgery, King's College Hospital, London, UK., Ludwig B; Department of Medicine III and Paul Langerhans Institute Dresden, Helmholtz Center Munich, University Hospital Carl Gustav Carus, Dresden, Germany; Department of Endocrinology and Diabetology, University Hospital Zurich, Zurich, Switzerland; Faculty of Medicine, Technische Universität Dresden, Dresden, Germany; Deutsche Forschungsgemeinschaft Center for Regenerative Therapies Dresden, Technische Universität Dresden, Dresden, Germany; German Center for Diabetes Research, Neuherberg, Germany. |
| Source: | The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2020 Aug; Vol. 8 (8), pp. 669-670. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: The Lancet, Diabetes & Endocrinology Country of Publication: England NLM ID: 101618821 Publication Model: Print Cited Medium: Internet ISSN: 2213-8595 (Electronic) Linking ISSN: 22138587 NLM ISO Abbreviation: Lancet Diabetes Endocrinol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
